SURGE
Back to Stacks

SURGE

CJC-1295 WO/Dac + Ipamorelin

Growth hormone, synergistically amplified.

Rp 1.400.000
5mg + 5mg per vial
Mix 3+ products for 20% off. Bacteriostatic water excluded.

Order Inclusions

1 × 3mL BAC WaterIncluded
Free instant deliveryDelivered today
Alcohol wipes & syringesIncluded
Inside this protocol

Peptides, precisely combined.

CJC-1295 WO/Dac5mg

Growth hormone, pulsed naturally.

Ipamorelin5mg

Growth hormone, optimized.

Why this protocol
  • Combines two GH signals for a stronger, more sustained response than either alone
  • Supports muscle growth and maintenance without the downsides of synthetic GH
  • Speeds up recovery so you feel ready to train again sooner
  • No cortisol or stress hormone spike, giving you all the recovery without the baggage

Surge Stack Research Notes

What is Surge?

Surge combines CJC-1295 No DAC and Ipamorelin — the two most studied growth hormone secretagogues — in a single pre-configured vial. They are paired because they stimulate GH release via entirely different receptor pathways, making them synergistic rather than redundant.

CJC-1295 No DAC is a GHRH analogue. It acts on the GHRH receptor in the pituitary to stimulate GH release — mimicking the body's own growth hormone releasing hormone. Ipamorelin is a GHRP. It acts on the ghrelin receptor — a completely separate pathway — to produce additional GH release. When used together, the two mechanisms produce significantly greater GH output than either compound alone, while Ipamorelin's selective profile ensures no significant cortisol or prolactin elevation at research doses.

The result is a pulsatile GH stimulation pattern that mirrors natural GH secretion — relevant for researchers studying body composition, recovery, metabolic function, and the effects of optimised GH axis activity.

What the research shows

  • Dual pathway GH stimulation: GHRH receptor and ghrelin receptor activation together produce synergistic GH output documented in animal and human studies — greater than either compound alone.

  • Ipamorelin selectivity: Ipamorelin does not significantly elevate cortisol, prolactin, or ACTH at doses that produce meaningful GH release — a key differentiator from older secretagogues like GHRP-2 and GHRP-6.

  • CJC-1295 No DAC pulsatility: Its short half-life of approximately 30 minutes produces a GH pulse that clears quickly, preserving natural feedback regulation.

  • Body composition: GH-mediated improvements in lean mass and fat metabolism are documented in animal studies consistent with the class.

Ordering Surge in Bali

Surge is supplied strictly for research use. Confirm current availability, the applicable product records, and delivery options for the exact Bali address before ordering.

Common Questions

Q: Why is the No DAC version used rather than CJC-1295 with DAC?

No DAC has a short half-life, producing pulsatile GH release that mirrors natural secretion patterns. With DAC has a half-life of approximately 8 days, producing sustained GH elevation. Most researchers pair Ipamorelin with No DAC specifically for the pulsatile profile.

Q: When do researchers typically administer Surge?

Most commonly before sleep or fasted in the morning to align with the body's natural GH pulse timing. Both components work on the same schedule in this stack.

Q: Can it be combined with other stacks?

Surge is sometimes researched alongside Rebuild for combined recovery and GH axis support. It is also commonly paired with NAD+ or MOTS-c in longevity and performance protocols.

Q: Storage?

Refrigerate at 2–8°C. Use within 28 days of reconstitution. Ships cold-packed with a thermafreeze ice pack.